Moderna Inc. will provide as many as 100 million doses of COVID-19 shots that specifically target variants for vaccine alliance GAVI to distribute in lower-income countries in 2023. Under the agreement, Moderna will supply these mRNA variant-targeting shots for...
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi
In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World...
